Naturally inspired. Engineered to deliver.

Transformative exosome therapeutics

About Us

Evox’s mission is to build a platform-driven technology company to spearhead the development of exosome therapeutics for the treatment of serious, life-threatening rare diseases where there are currently limited treatment options for patients and their families.

Pipeline Evox is developing an internal and partnered pipeline of exosome-based therapeutics for treating life-threatening rare diseases.

Partners Evox seeks partners that can leverage the power of our DeliverEX™ platform, as well as those who can help advance our rare disease programs.

Technology

Evox combines the highly versatile delivery capabilities of exosomes with targeting technology and sophisticated biomolecular engineering approaches.

Our Science

Utilizing the DeliverEX^® platform, Evox is developing an internal and partnered pipeline of exosome-based therapeutics for treating life-threatening rare diseases.

Latest News

Evox Therapeutics Granted Key US Exosome Purification Patent to Further Expand Its Leading Patent Portfolio

May 17, 2023

Evox Therapeutics Presents Progress Across its DeliverEX® Platform Highlighting Advances in Exosome-Mediated Delivery of Genetic Medicines Including Gene Editing and RNA Therapeutics

May 12, 2023

Evox Therapeutics Expands its Exosome Manufacturing Patent Portfolio

September 7, 2022

Evox announced that the Company has been granted four newly issued patents covering key purification processes and methods of exogenous loading